{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:55:00Z","timestamp":1786982100219,"version":"build-2736575974"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T00:00:00Z","timestamp":1667779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T00:00:00Z","timestamp":1667779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ir J Med Sci"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1007\/s11845-022-03204-6","type":"journal-article","created":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T18:26:20Z","timestamp":1667845580000},"page":"1785-1791","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Serum PCSK9 is positively correlated with disease activity and Th17 cells, while its short-term decline during treatment reflects desirable outcomes in ankylosing spondylitis patients"],"prefix":"10.1007","volume":"192","author":[{"given":"Jianfei","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinghui","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fucai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjun","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7652-3081","authenticated-orcid":false,"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,7]]},"reference":[{"issue":"7","key":"3204_CR1","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41584-021-00625-y","volume":"17","author":"D Mauro","year":"2021","unstructured":"Mauro D, Thomas R, Guggino G et al (2021) Ankylosing spondylitis: an autoimmune or autoinflammatory disease? Nat Rev Rheumatol 17(7):387\u2013404. https:\/\/doi.org\/10.1038\/s41584-021-00625-y","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"3204_CR2","first-page":"19","volume":"102","author":"S Achar","year":"2020","unstructured":"Achar S, Yamanaka J (2020) Back pain in children and adolescents. Am Fam Physician 102(1):19\u201328","journal-title":"Am Fam Physician"},{"key":"3204_CR3","doi-asserted-by":"publisher","DOI":"10.1093\/mr\/roac081","author":"K Kishimoto","year":"2022","unstructured":"Kishimoto K, Asai S, Suzuki M et al (2022) Age and symptoms at onset of ankylosing spondylitis in Japanese patients. Mod Rheumatol. https:\/\/doi.org\/10.1093\/mr\/roac081","journal-title":"Mod Rheumatol"},{"issue":"6","key":"3204_CR4","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s00296-020-04537-0","volume":"40","author":"J Zhao","year":"2020","unstructured":"Zhao J, Huang C, Huang H et al (2020) Prevalence of ankylosing spondylitis in a Chinese population: a systematic review and meta-analysis. Rheumatol Int 40(6):859\u2013872. https:\/\/doi.org\/10.1007\/s00296-020-04537-0","journal-title":"Rheumatol Int"},{"issue":"5","key":"3204_CR5","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s40259-020-00442-x","volume":"34","author":"CL Yu","year":"2020","unstructured":"Yu CL, Yang CH, Chi CC (2020) Drug survival of biologics in treating ankylosing spondylitis: a systematic review and meta-analysis of real-world evidence. BioDrugs 34(5):669\u2013679. https:\/\/doi.org\/10.1007\/s40259-020-00442-x","journal-title":"BioDrugs"},{"issue":"4","key":"3204_CR6","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/s41584-022-00761-z","volume":"18","author":"A Danve","year":"2022","unstructured":"Danve A, Deodhar A (2022) Treatment of axial spondyloarthritis: an update. Nat Rev Rheumatol 18(4):205\u2013216. https:\/\/doi.org\/10.1038\/s41584-022-00761-z","journal-title":"Nat Rev Rheumatol"},{"key":"3204_CR7","doi-asserted-by":"publisher","unstructured":"Popa SL, Dumitrascu DI, Brata VD et al (2022) Nutrition in spondyloarthritis and related immune-mediated disorders. Nutrients 14(6). https:\/\/doi.org\/10.3390\/nu14061278","DOI":"10.3390\/nu14061278"},{"issue":"8","key":"3204_CR8","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1136\/annrheumdis-2020-219601","volume":"80","author":"A Deodhar","year":"2021","unstructured":"Deodhar A, Sliwinska-Stanczyk P, Xu H et al (2021) Tofacitinib for the treatment of ankylosing spondylitis: a phase III, randomised, double-blind, placebo-controlled study. Ann Rheum Dis 80(8):1004\u20131013. https:\/\/doi.org\/10.1136\/annrheumdis-2020-219601","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"3204_CR9","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s13075-020-02208-w","volume":"22","author":"Y Yin","year":"2020","unstructured":"Yin Y, Wang M, Liu M et al (2020) Efficacy and safety of IL-17 inhibitors for the treatment of ankylosing spondylitis: a systematic review and meta-analysis. Arthritis Res Ther 22(1):111. https:\/\/doi.org\/10.1186\/s13075-020-02208-w","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"3204_CR10","doi-asserted-by":"publisher","first-page":"970","DOI":"10.2174\/0929867328666210810150940","volume":"29","author":"S Ministrini","year":"2022","unstructured":"Ministrini S, Carbone F (2022) PCSK9 and inflammation: their role in autoimmune diseases, with a focus on rheumatoid arthritis and systemic lupus erythematosus. Curr Med Chem 29(6):970\u2013979. https:\/\/doi.org\/10.2174\/0929867328666210810150940","journal-title":"Curr Med Chem"},{"issue":"5","key":"3204_CR11","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1093\/cvr\/cvz313","volume":"116","author":"Z Ding","year":"2020","unstructured":"Ding Z, Pothineni NVK, Goel A et al (2020) PCSK9 and inflammation: role of shear stress, pro-inflammatory cytokines, and LOX-1. Cardiovasc Res 116(5):908\u2013915. https:\/\/doi.org\/10.1093\/cvr\/cvz313","journal-title":"Cardiovasc Res"},{"issue":"6","key":"3204_CR12","doi-asserted-by":"publisher","DOI":"10.4110\/in.2019.19.e41","volume":"19","author":"YU Kim","year":"2019","unstructured":"Kim YU, Kee P, Danila D, Teng BB (2019) A critical role of PCSK9 in mediating IL-17-producing T cell responses in hyperlipidemia. Immune Netw 19(6):e41. https:\/\/doi.org\/10.4110\/in.2019.19.e41","journal-title":"Immune Netw"},{"issue":"9","key":"3204_CR13","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1093\/cvr\/cvaa254","volume":"117","author":"L Badimon","year":"2021","unstructured":"Badimon L, Luquero A, Crespo J et al (2021) PCSK9 and LRP5 in macrophage lipid internalization and inflammation. Cardiovasc Res 117(9):2054\u20132068. https:\/\/doi.org\/10.1093\/cvr\/cvaa254","journal-title":"Cardiovasc Res"},{"issue":"1","key":"3204_CR14","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13075-020-02386-7","volume":"23","author":"J Frostegard","year":"2021","unstructured":"Frostegard J, Ahmed S, Hafstrom I et al (2021) Low levels of PCSK9 are associated with remission in patients with rheumatoid arthritis treated with anti-TNF-alpha: potential underlying mechanisms. Arthritis Res Ther 23(1):32. https:\/\/doi.org\/10.1186\/s13075-020-02386-7","journal-title":"Arthritis Res Ther"},{"key":"3204_CR15","doi-asserted-by":"publisher","unstructured":"Fang C, Luo T, Lin L (2018) Elevation of serum proprotein convertase subtilisin\/kexin type 9 (PCSK9) concentrations and its possible atherogenic role in patients with systemic lupus erythematosus. Ann Transl Med 6(23):452. https:\/\/doi.org\/10.21037\/atm.2018.11.04","DOI":"10.21037\/atm.2018.11.04"},{"issue":"5","key":"3204_CR16","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1093\/rheumatology\/keaa590","volume":"60","author":"L de Armas-Rillo","year":"2021","unstructured":"de Armas-Rillo L, Quevedo-Abeledo JC, de Vera-Gonzalez A et al (2021) Proprotein convertase subtilisin\/kexin type 9 in the dyslipidaemia of patients with axial spondyloarthritis is related to disease activity. Rheumatology (Oxford) 60(5):2296\u20132306. https:\/\/doi.org\/10.1093\/rheumatology\/keaa590","journal-title":"Rheumatology (Oxford)"},{"key":"3204_CR17","doi-asserted-by":"publisher","unstructured":"Sieper J, Rudwaleit M, Baraliakos X et al (2009) The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis. Ann Rheum Dis 68(Suppl 2):ii1\u201344. https:\/\/doi.org\/10.1136\/ard.2008.104018","DOI":"10.1136\/ard.2008.104018"},{"key":"3204_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.875341","volume":"9","author":"B Dou","year":"2022","unstructured":"Dou B, Ma F, Jiang Z, Zhao L (2022) Blood HDAC4 Variation links with disease activity and response to tumor necrosis factor inhibitor and regulates CD4+ T cell differentiation in ankylosing spondylitis. Front Med (Lausanne) 9:875341. https:\/\/doi.org\/10.3389\/fmed.2022.875341","journal-title":"Front Med (Lausanne)"},{"key":"3204_CR19","doi-asserted-by":"publisher","unstructured":"Sanchez-Perez H, Quevedo-Abeledo JC, Tejera-Segura B et al (2020) Proprotein convertase subtilisin\/kexin type 9 is related to disease activity and damage in patients with systemic erythematosus lupus. Ther Adv Musculoskelet Dis 12:1759720X20975904. https:\/\/doi.org\/10.1177\/1759720X20975904","DOI":"10.1177\/1759720X20975904"},{"key":"3204_CR20","unstructured":"Ferraz-Amaro I, Delgado-Frias E, Hernandez-Hernandez V et al (2020) Proprotein convertase subtilisin\/kexin type 9 in patients with systemic sclerosis. Clin Exp Rheumatol 38 Suppl 125(3):18\u201324"},{"issue":"9","key":"3204_CR21","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1097\/MCG.0000000000001607","volume":"56","author":"C Marinelli","year":"2022","unstructured":"Marinelli C, Zingone F, Lupo MG et al (2022) Serum levels of PCSK9 are increased in patients with active ulcerative colitis representing a potential biomarker of disease activity: a cross-sectional study. J Clin Gastroenterol 56(9):787\u2013793. https:\/\/doi.org\/10.1097\/MCG.0000000000001607","journal-title":"J Clin Gastroenterol"},{"key":"3204_CR22","doi-asserted-by":"publisher","unstructured":"Krahel JA, Baran A, Kaminski TW et al (2020) Methotrexate decreases the level of PCSK9-a novel indicator of the risk of proatherogenic lipid profile in psoriasis. The Preliminary Data. J Clin Med 9(4). https:\/\/doi.org\/10.3390\/jcm9040910","DOI":"10.3390\/jcm9040910"},{"key":"3204_CR23","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.atherosclerosis.2019.02.001","volume":"283","author":"AA Momtazi-Borojeni","year":"2019","unstructured":"Momtazi-Borojeni AA, Jaafari MR, Badiee A, Sahebkar A (2019) Long-term generation of antiPCSK9 antibody using a nanoliposome-based vaccine delivery system. Atherosclerosis 283:69\u201378. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2019.02.001","journal-title":"Atherosclerosis"},{"issue":"10","key":"3204_CR24","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1002\/art.41042","volume":"71","author":"MM Ward","year":"2019","unstructured":"Ward MM, Deodhar A, Gensler LS et al (2019) 2019 Update of the American College of Rheumatology\/Spondylitis Association of America\/Spondyloarthritis Research and Treatment Network recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis. Arthritis Rheumatol 71(10):1599\u20131613. https:\/\/doi.org\/10.1002\/art.41042","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"3204_CR25","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/imm.13242","volume":"161","author":"A Voruganti","year":"2020","unstructured":"Voruganti A, Bowness P (2020) New developments in our understanding of ankylosing spondylitis pathogenesis. Immunology 161(2):94\u2013102. https:\/\/doi.org\/10.1111\/imm.13242","journal-title":"Immunology"},{"issue":"2","key":"3204_CR26","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1002\/acr.23259","volume":"70","author":"B Arnbak","year":"2018","unstructured":"Arnbak B, Jurik AG, Jensen TS, Manniche C (2018) Association between inflammatory back pain characteristics and magnetic resonance imaging findings in the spine and sacroiliac joints. Arthritis Care Res (Hoboken) 70(2):244\u2013251. https:\/\/doi.org\/10.1002\/acr.23259","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"5","key":"3204_CR27","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.5114\/aoms\/133885","volume":"17","author":"AA Momtazi-Borojeni","year":"2021","unstructured":"Momtazi-Borojeni AA, Jaafari MR, Afshar M et al (2021) PCSK9 immunization using nanoliposomes: preventive efficacy against hypercholesterolemia and atherosclerosis. Arch Med Sci 17(5):1365\u20131377. https:\/\/doi.org\/10.5114\/aoms\/133885","journal-title":"Arch Med Sci"}],"container-title":["Irish Journal of Medical Science (1971 -)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-022-03204-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11845-022-03204-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-022-03204-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T06:22:57Z","timestamp":1690784577000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11845-022-03204-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,7]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["3204"],"URL":"https:\/\/doi.org\/10.1007\/s11845-022-03204-6","relation":{},"ISSN":["0021-1265","1863-4362"],"issn-type":[{"value":"0021-1265","type":"print"},{"value":"1863-4362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,7]]},"assertion":[{"value":"26 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was permitted by the Ethics Committee of Shanghai Qiangzhi Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Each subject signed the informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}